Pharmaceutical freedom : why patients have a right to self medicate / Jessica Flanigan.

Includes bibliographical references and index.

Online resource, title from PDF title page (EBSCO, viewed June 27, 2017).

Cover; Pharmaceutical Freedom; Copyright; Contents; Acknowledgments; Introduction; 1. A Defense of Self-​Medication; 1.1 Two Motivating Cases; 1.2 Patients Know Best; 1.3 Patient Expertise and Drug Choice; 1.4 Intimate Choices; 1.5 Anti-​paternalism and Freedom to Choose; 1.6 Patient Protection; 1.7 Ignorance and Fraud; 1.8 Self-​Medication and Unapproved Drugs; 1.9 Self-​Medication and Prescription Drugs; 1.10 Conclusion; 2. Paternalism and Public Health; 2.1 Prohibition and Protection; 2.2 Soft Paternalism and Drug Regulation; 2.3 Children and Incompetent Adults

2.4 Hard Paternalism and Drug Regulation2.5 The Health Effects of Approval Requirements; 2.6 The Health Effects of Prescription Policies; 2.7 The Regulatory Reversal Test; 2.8 Certification Versus Approval; 2.9 Conclusion; 3. Rethinking Prescription Requirements; 3.1 Deadly Drugs; 3.2 Recreational Drugs and Addiction; 3.3 Therapeutics; 3.4 Antibiotics; 3.5 The Case for OTC Enhancements; 3.6 Rethinking Non-​Medical Use; 3.7 Public Health and Preventive Medication; 3.8 Conclusion; 4. Responsibility and Regulation; 4.1 How Regulation Kills; 4.2 Necessity and the Need to Test

4.3 Non-​Ideal and Ideal Theory4.4 The Risks of an Approval System; 4.5 The Risks of a Certification System; 4.6 Conclusion; 5. The Politics of Self-​Medication; 5.1 Patient-​Driven Development; 5.2 Disobedience and Distribution; 5.3 Civil Disobedience; 5.4 Protest and Activism; 5.5 Democratic Authority and Self-​Medication; 5.6 Conclusion; 6. The Business of Medicine; 6.1 Single Standards for Industry; 6.2 Private Options and the Global Marketplace; 6.3 Drug Prices and Deregulation; 6.4 Lifesaving Innovation and Patents; 6.5 Patents and Prizes; 6.6 Patents and the Rights of Producers

6.7 Conclusion7. Medical Autonomy and Modern Healthcare; 7.1 Markets and Medical Autonomy; 7.2 Pharmaceutical Marketing; 7.3 Off-​Label Marketing; 7.4 Professional Ethics; 7.5 Torts and Product Liability; 7.6 Insurance and Social Costs; 7.7 Conclusion; 8. Conclusion; References; Index

Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide